. 1976 Oct;58(2):272P.

Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?

G W Arbuthnott et al. Br J Pharmacol. 1976 Oct.

. 1976 Oct;58(2):272P.

No abstract available

Similar articles

Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
Straughan DW, James TA. Straughan DW, et al. Int J Neurol. 1979;13(1-4):81-93. Int J Neurol. 1979. PMID: 122391 Review. No abstract available.
Behavioural and neurochemical studies on the striatonigral GABA pathway [proceedings].
Cross AJ, Waddington JL. Cross AJ, et al. Br J Pharmacol. 1979 Jul;66(3):477P-478P. Br J Pharmacol. 1979. PMID: 526755 Free PMC article. No abstract available.
Rotational behaviour and striatal dopamine metabolism following unilateral activation of nigral GABA mechanisms: GABA-like modulation of dopaminergic and non-dopaminergic neurons in rat substantia nigra [proceedings].
Waddington JL. Waddington JL. Br J Pharmacol. 1978 Jun;63(2):384P. Br J Pharmacol. 1978. PMID: 566600 Free PMC article. No abstract available.
Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
Gale K, Costa E, Toffano G, Hong JS, Guidotti A. Gale K, et al. J Pharmacol Exp Ther. 1978 Jul;206(1):29-37. J Pharmacol Exp Ther. 1978. PMID: 26799 No abstract available.
[Stereotyped behavior and the nigro-strio-nigral system].
Arushanian EB. Arushanian EB. Zh Vyssh Nerv Deiat Im I P Pavlova. 1985 Sep-Oct;35(5):819-32. Zh Vyssh Nerv Deiat Im I P Pavlova. 1985. PMID: 2866641 Review. Russian. No abstract available.